Wolfe Research analyst Tim Anderson downgrades AbbVie (NYSE:ABBV) from Outperform to Peer Perform.
Monitoring Board Recommends NRx Pharma’s Suicidal Bipolar Depression Study To Continue Enrollment
NRx Pharmaceuticals Inc (NASDAQ:NRXP) reported that the independent Data Safety Monitoring Board (DSMB) reviewed the safety and efficacy findings of the…